Maggie Tibbitt


Retifanlimab shows promising antitumor activity in advanced endometrial cancer

Retifanlimab demonstrated encouraging antitumor activity with favorable tolerability in patients with recurrent microsatellite instability–high or mismatch repair deficient endometrial cancer, according to data from the phase 1 POD1UM-101 trial.

Linda Stocum


STDs and dermatologic symptoms

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases (STDs) to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Jamie O. Lo, MD


Impact of marijuana: Frequently asked questions

With growing public endorsement of the potential benefits of marijuana, it is important for health care providers to effectively counsel patients regarding its effects on fertility and future offspring.

Julia Malits


Beware of “forever chemicals”

Counsel pregnant and breastfeeding patients about dangers from exposure to PFAS.

Jessica Ayre


HIPAA mistakes to avoid when texting patients

While texting can make things a lot easier (and more profitable), it can also be easy to unknowingly violate HIPAA regulations.

Lindsey Carr, Editor


In case you missed it: January 16 to January 20

Take a look back at this week's top stories.

Erin O'Brien


Study examines best practices for managing perinatal depression

Recommendations are often vague, contradictory, according to investigators.

Santosh Pandipati, MD


Panel discussion: Impacts of climate change on women's health

Senior Editor Angie DeRosa sat down Drs. Bekkar, DeNicola, Pandipati and Abel to discuss findings from a recent study on the association with air pollution and heat exposure with adverse obstetrical outcomes, such as preterm birth and stillbirth.

Sonal Jain, DO


Perspectives on global women’s mental health

This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.

Abby Reinhard


Higher recurrence risk, triptan use linked to perimenstrual migraine duration

Women with perimenstrual migraine attacks may also be at increased risk of medication overuse.

Alexandra Hanretty, PharmD


UTIs: Why did you have to go and make things so complicated?

Although hospitalizations due to urinary tract infections have increased, there are some investigational antibiotics in clinical trials. Here is a review of some of these therapies in the pipeline.

Abigail Brooks, MA


Oral menopause hormone therapy linked to increased risk of NAFLD

The presence of NAFLD increased from 25.3% to 29.4% among patients receiving oral menopause hormone therapy.

Washington Hill, MD


Ensuring racial justice and health equity in ob/gyn

“In the past 55 years since I became a physician, progress has been made but we still have so much more to do and a long way to go.”

Alla Vash-Margita, MD


Cervical cancer screening guidelines for adolescents

Teenaged girls at average risk don’t need Papanicolaou tests, but some special populations do.

Jennifer McCoy, MD


SMFM Consult Series #60: Management of pregnancies resulting from IVF

This Consult discusses the management of pregnancies achieved with in vitro fertilization and provides recommendations based on the available evidence.

Tricia Wright, MD, MS


Alcohol and breastfeeding: What are the risks?

What are the impacts of alcohol use during lactation?

Deepika Sagaram, MD


Physician burnout and self-care

During the pandemic, physician self-care and organizational efforts to protect physician wellbeing are vital to maintaining a healthy and able workforce, which in turn enables a strong response to the ongoing health crisis.

Molly B. Moravek, MD, MPH, MSCI


Planned oocyte cryopreservation

Learn how and when to counsel your patients.

Hindi Stohl, MD, JD


Documentation saves the day

Learn how documentation can significantly benefit patients and providers.

Rich Parker, MD


The impact of vaccines on long COVID-19

Research suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.

Nada L. Stotland, MD, MPH


Abortion: Just the tip of the iceberg

Considering the many repercussions of overturning Roe v Wade—and the psychiatric implications for our patients.

Marisa C. Liu, MD


Vaginal Dilators: A guide for health care professionals

These therapeutic medical devices can be used by patients to effectively treat pelvic pain and anxiety related to intercourse.

Brandon Daniell


8 ways texting can improve patient retention and boost revenue

Why text messaging is good for the business of health care

Chelsea King Arthur


The patient experience matters

Actionable patient data lives in your digital engagement tools — use it!

Katherine Vanhise, MD


Getting a grip on polycystic ovary syndrome

A diagnosis and management refresher.

Jamie Cesanek


New biomarker could predict immunotherapy benefit in breast cancer

The Major Histocompatibility Complex Class II protein has potential to predict immunotherapy benefit in two types of breast cancer.

Kate Pierce


The time is now for federal agencies to fortify cybersecurity among small and rural hospitals

As physicians focus on patient health and executives work to keep the doors open, data breaches can have serious consequences for everyone.

Yifan Emily Chang, MD


Deep dive into HPV vaccines

A safety and efficacy refresher

Mia Dekel


Pruritic rash in vulvovaginal area of 2-year-old girl

Three months ago, a healthy 2-year-old girl presented with a mildly pruritic rash with erythematous plaques, some silvery white, in the vulvovaginal area. She had no vaginal discharge or other symptoms. The rash is now more widespread, and new lesions have recently appeared on her lower back and thighs. What's the diagnosis?

© 2023 MJH Life Sciences

All rights reserved.